SCHEMBL2897125

SCHEMBL2897125

CCCCCn1ncc2c(N)c(C(=O)N(O)CC)cnc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1057330 0.84
SCHEMBL5927938 0.84
SCHEMBL1056632 0.81
SCHEMBL1059182 0.81
SCHEMBL1050892 0.80
SCHEMBL1059283 0.76
SCHEMBL1058243 0.74
SCHEMBL1058787 0.73
SCHEMBL1058823 0.73
SCHEMBL1081086 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1982704-B1 New molecular target of neurotoxicity EXONHIT THERAPEUTICS SA (FR) 2010-08-04 EP claimed
US-20090317842-A1 Methods and Tools for The Therapy of Neurodegenerative Pathologies EXONHIT THERAPEUTICS SA (FR) 2009-12-24 US disclosed
EP-2047277-A2 METHODS AND TOOLS FOR THE THERAPY OF NEURODEGENERATIVE PATHOLOGIES Exonhit Therapeutics SA (FR) 2009-04-15 EP disclosed
WO-2008009868-A2 METHODS AND TOOLS FOR THE THERAPY OF NEURODEGENERATIVE PATHOLOGIES EXONHIT THERAPEUTICS SA (FR) 2008-01-24 WO disclosed
EP-0180318-B1 AMIDE DERIVATIVES ICI AMERICAS INC. (US) 1991-11-06 EP disclosed
US-4745121-A AMINE OR CARBOXAMIDE SUBSTITUTED ICI AMERICAS INC. (US) 1988-05-17 US disclosed
EP-0180318-A1 Amide derivatives ICI AMERICAS INC. (US) 1986-05-07 EP disclosed